Table 3 Hazard ratios of demographic and clinical parameters obtained by log-rank test
Characteristic | HR | 95% CI | p-value |
|---|---|---|---|
Age | 1.7413 | 0.8202 to 3.6965 | 0.150 |
Sex | 1.5123 | 0.7092 to 3.2250 | 0.280 |
Surgery | 0.05810 | 0.01923 to 0.1755 |  < 0.0001 |
Adjuvant therapy | 0.3638 | 0.1639 to 0.8076 | 0.013 |
Neo-adjuvant therapy | 0.8056 | 0.3563 to 1.8213 | 0.600 |
First-line therapy | 0.8185 | 0.3568 to 1.8773 | 0.630 |
T (T3-4 vs T1-2) stage | 9.5881 | 1.4152 to 64.962 | 0.026 |
N (N2 vs N1) stage | 2.3826 | 0.9539 to 5.9511 | 0.063 |
M stage (M1 vs M0) | 266 | 28 to 2563 |  < 0.0001 |